Results 101 to 110 of about 9,259 (230)

Lithuanian haemophilia A and B registry comprising phenotypic and genotypic data [PDF]

, 2001
Vytautas Ivaškevičius, Romualdas Jurgutis, Simone Rost, Alexandra Müller, Christoph Schmitt, K. Wulff, Falko H. Herrmann, Clemens R. Müller, R. Schwaab, Johannes Oldenburg   +9 more
openalex   +1 more source

Treatment and Disease Burden in a Cohort of People With Haemophilia Without Inhibitors in the United States

Haemophilia, EarlyView.
ABSTRACT Introduction Haemophilia is a bleeding disorder caused by a deficiency in coagulation factors VIII or IX. Great advances in haemophilia treatment have been achieved in recent decades, with a range of products for prophylaxis now available, the ability to individualise therapy, and resultant improvements in life expectancy and quality of life ...
Allison P. Wheeler, Emily Cibelli, Gillian Hanson, Cléa Percier, Thomas Porstmann, Naveen Shridhar, Amy Shapiro   +6 more
wiley   +1 more source

Haemophilia B mutations in Sweden: a population‐based study of mutational heterogeneity [PDF]

, 2001
Rolf Ljung, Pia Petrini, Lilian Tengborn, Elsy Sjörin   +3 more
openalex   +1 more source

Factors Influencing Symptoms of Depression, Anxiety and Stress in Patients With Haemophilia

Haemophilia, EarlyView.
ABSTRACT Introduction Patients with haemophilia (PwH) often suffer from psychological symptoms such as depression or anxiety. To date, uncertainty exists about the determinants predicting worse psychological outcomes. Therefore, this study aimed to investigate the extent of depressive, anxiety and stress‐related symptoms in PwH compared to the healthy ...
Alexander Schmidt, Fabian Tomschi, Pia Möllers, Marius Brühl, Heinrich Richter, Johannes Oldenburg, Andreas Christian Strauss, Thomas Hilberg   +7 more
wiley   +1 more source

Mutation analysis and characterisation of F9 gene in haemophilia- B population of India. [PDF]

Blood Res, 2021
Kulkarni S, Hegde R, Hegde S, Kulkarni SS, Hanagvadi S, Das KK, Kolagi S, Gai PB, Bulagouda R.   +8 more
europepmc   +1 more source

A protocol for the dental management of von Willebrand's disease, haemophilia A and haemophilia B [PDF]

, 2001
Malcolm J. Stubbs, J. V. Lloyd
openalex   +1 more source

Measuring Physical Function Capacity in Persons With Haemophilia: A Systematic Review of Performance‐Based Methods

Haemophilia, EarlyView.
ABSTRACT Introduction Currently, physical health assessments in persons with haemophilia focus on bleed‐related events and after‐effects. The aim of the systematic review was to review and apply standardised criteria to evaluate reliability, responsiveness and construct validity of performance‐based instruments evaluating physical capability in persons
Catherine Holdsworth, Melanie Bladen, Hannah Harbidge, Wendy Drechsler, Ryan Mahaffey, Sofia Perez‐Alenda, Fionnuala Sayers, Karen Strike, Merel Timmer, David Stephensen   +9 more
wiley   +1 more source

Quality of life in a large multinational haemophilia B cohort (The B-Natural study) - Unmet needs remain. [PDF]

Haemophilia, 2022
Berntorp E, LeBeau P, Ragni MV, Borhany M, Abajas YL, Tarantino MD, Holstein K, Croteau SE, Liesner R, Tarango C, Carvalho M, McGuinn C, Funding E, Kempton CL, Bidlingmaier C, Cohen A, Oldenburg J, Kearney S, Knoll C, Kuriakose P, Acharya S, Reiss UM, Kulkarni R, Witkop M, Lethagen S, Krouse R, Shapiro AD, Astermark J.   +27 more
europepmc   +1 more source

Safety and Use of Eptacog Beta 225 µg/kg in Patients With Haemophilia A or B With Inhibitors

Haemophilia, EarlyView.
Introduction Eptacog beta is an activated recombinant human factor VII bypassing agent approved for treating bleeding episodes (BEs) in patients aged ≥12 years with haemophilia A or B with inhibitors. Two initial dose regimens (IDRs) of either 75 or 225 µg/kg, followed by 75 µg/kg, are approved.
Manuel Carcao, Cédric Hermans, Adam Giermasz, Craig Kessler, Wolfgang Miesbach, Doris Quon, Jerzy Windyga, Johnny Mahlangu   +7 more
wiley   +1 more source

Preclinical development of plant-based oral immune modulatory therapy for haemophilia B. [PDF]

Plant Biotechnol J, 2021
Srinivasan A, Herzog RW, Khan I, Sherman A, Bertolini T, Wynn T, Daniell H.   +6 more
europepmc   +1 more source